EUVIMEDEUVIMED entdecken
Open Access

A drug that induces the microRNA miR-124 enables differentiation of retinoic acid–resistant neuroblastoma cells

Lien D Nguyen iD, Satyaki Sengupta, Kevin I Cho iD, Alexander Floru iD, Rani E George iD, Anna M Krichevsky iD

Science Signaling · 15.04.2025 · 18 (882)

DOI: 10.1126/scisignal.ads2641 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Signaling, erschienen am 15.04.2025. Verfasst von Lien D Nguyen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA. Hauptthemen laut MEDLINE: MicroRNAs, Neuroblastoma, Tretinoin, Drug Resistance, Neoplasm. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tumor cell heterogeneity in neuroblastoma, a pediatric cancer arising from neural crest–derived progenitor cells, presents clinical challenges. Unlike adrenergic (ADRN) neuroblastoma cells, neuroblastoma cells with a mesenchymal (MES) identity are resistant to chemotherapy and retinoid therapy, which contributes to relapses and treatment failures. We explored whether up-regulation of the neurogenic, tumor suppressor microRNA miR-124 could promote the differentiation of retinoic acid–resistant MES neuroblastoma cells. Leveraging our screen for miRNA-modulatory small molecules, we identified and validated the tyrosine and phosphoinositide kinase inhibitor PP121 as a robust inducer of miR-124. Combining PP121 and BDNF-activating bufalin synergistically arrested proliferation and promoted the sustained differentiation of MES/heterogeneous SK-N-AS cells over several weeks. This protocol also resulted in the differentiation of multiple MES neuroblastoma and glioblastoma cell lines. RNA-seq analysis of differentiated MES/heterogeneous SK-N-AS cells revealed the replacement of the ADRN core regulatory circuitry with circuitries associated with chromaffin cells and Schwann cell precursors. Furthermore, differentiation was associated with inhibition of the CDK4/CDK6 pathway and activation of a transcriptional program that correlated with improved outcomes for patients with neuroblastoma. Our findings suggest an approach with translational potential to induce the differentiation of therapy-resistant cancers of the nervous system. Moreover, these long-lived, differentiated cells could be used to study mechanisms underlying cancer biology and therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsNeuroblastomaTretinoinDrug Resistance, NeoplasmCell DifferentiationHumansCell Line, TumorGene Expression Regulation, NeoplasticCell ProliferationBrain-Derived Neurotrophic FactorCyclin-Dependent Kinase 6

Substanzen

MicroRNAsTretinoinMIRN124 microRNA, humanBrain-Derived Neurotrophic FactorCyclin-Dependent Kinase 6

Autor:innen und Institutionen

  • Department of Neurology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA.
  • Department of Pediatric Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, 02115, USA.

ORCID-Profile: Lien D Nguyen, Kevin I Cho, Alexander Floru, Rani E George, Anna M Krichevsky

Förderung

  • NCI NIH HHS

Zitieren

APA

Nguyen, L. D., Sengupta, S., Cho, K. I., Floru, A., George, R. E., & Krichevsky, A. M. (2025). A drug that induces the microRNA miR-124 enables differentiation of retinoic acid–resistant neuroblastoma cells. Science Signaling, 18(882). https://doi.org/10.1126/scisignal.ads2641

Vancouver

Nguyen LD, Sengupta S, Cho KI, Floru A, George RE, Krichevsky AM. A drug that induces the microRNA miR-124 enables differentiation of retinoic acid–resistant neuroblastoma cells. Science Signaling. 2025;18(882). doi:10.1126/scisignal.ads2641

BibTeX
@article{Nguyen2025,
  author = {Nguyen, Lien D and Sengupta, Satyaki and Cho, Kevin I and Floru, Alexander and George, Rani E and Krichevsky, Anna M},
  title = {A drug that induces the microRNA miR-124 enables differentiation of retinoic acid–resistant neuroblastoma cells},
  journal = {Science Signaling},
  year = {2025},
  volume = {18},
  number = {882},
  doi = {10.1126/scisignal.ads2641}
}
Kostenlos starten →